Old Web
English
Sign In
Acemap
>
Paper
>
Real Life Experience of Brentuximab Vedotin Plus CHP As First-Line Treatment in CD30 + Peripheral T-Cell Lymphomas
Real Life Experience of Brentuximab Vedotin Plus CHP As First-Line Treatment in CD30 + Peripheral T-Cell Lymphomas
2021
Domingo-Domenech Eva
Juan-Manuel Sancho
Eva González-Barca
Nicholas Kelleher
Marta Rodríguez-Luaces
Jordina Rovira Sole
Silvia Verdesoto
Maite Encuentra
Damir Blažević
Ana C. Oliveira
Lourdes Escoda
Josep-Maria Ribera
Anna Sureda
Keywords:
Oncology
CD30
Internal medicine
first line treatment
Brentuximab vedotin
Peripheral
T cell
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]